English
简体中文
Total: £ 56.28
Published Date: 2025-10-06 | Pages: 168 | Tables: 165 | More & Other
The global Pharmaceutical Glass Bottles and Jars market is projected to grow from US$ 3215 million in 2024 to US$ 4115 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Pharmaceutical glass packaging bottles are specialized containers designed for storing and transporting pharmaceutical products. They are typically made from neutral borosilicate glass or low borosilicate glass, ensuring excellent chemical stability, high-temperature resistance, and airtightness. These bottles are widely used for packaging injections, infusions, lyophilized powders, and oral solutions. Their transparency allows for easy observation of the contents, while effectively preventing moisture, oxidation, or chemical reactions with the container. Depending on the application, pharmaceutical glass packaging bottles include ampoules, vials, and infusion bottles, all manufactured under strict quality control standards to ensure the safety and efficacy of the pharmaceuticals.
From a downstream perspective, Injectable accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmaceutical Glass Bottles and Jars leading manufacturers including Gerresheimer, Schott, SGD, Nipro, Stevanato Group, Ardagh, Bormioli Pharma, West Pharmaceutical, Sisecam Group, Corning Incorporated, etc., dominate supply; the top five capture approximately % of global revenue, with Gerresheimer leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Glass Bottles and Jars market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Gerresheimer
Schott
SGD
Nipro
Stevanato Group
Ardagh
Bormioli Pharma
West Pharmaceutical
Sisecam Group
Corning Incorporated
PGP Glass
Stoelzle Glass
Shandong Pharmaceutical Glass
Roetell
Segment by Type
Type I Glass Bottles
Type II Glass Bottles
Type III Glass Bottles
Segment by Application
Injectable
Transfusion
Drug
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Pharmaceutical Glass Bottles and Jars study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Pharmaceutical Glass Bottles and Jars: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Glass Bottles and Jars Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Type I Glass Bottles
1.2.3 Type II Glass Bottles
1.2.4 Type III Glass Bottles
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Glass Bottles and Jars Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Injectable
1.3.3 Transfusion
1.3.4 Drug
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Glass Bottles and Jars Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Glass Bottles and Jars Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharmaceutical Glass Bottles and Jars Sales Estimates and Forecasts 2020-2031
2.4 Global Pharmaceutical Glass Bottles and Jars Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Pharmaceutical Glass Bottles and Jars Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Pharmaceutical Glass Bottles and Jars Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Type I Glass Bottles Market Size by Manufacturers
3.5.2 Type II Glass Bottles Market Size by Manufacturers
3.5.3 Type III Glass Bottles Market Size by Manufacturers
3.6 Global Pharmaceutical Glass Bottles and Jars Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceutical Glass Bottles and Jars Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceutical Glass Bottles and Jars Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceutical Glass Bottles and Jars Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Pharmaceutical Glass Bottles and Jars Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Pharmaceutical Glass Bottles and Jars Sales and Revenue by Type (2020-2031)
6.4 North America Pharmaceutical Glass Bottles and Jars Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceutical Glass Bottles and Jars Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Pharmaceutical Glass Bottles and Jars Sales and Revenue by Type (2020-2031)
7.4 Europe Pharmaceutical Glass Bottles and Jars Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceutical Glass Bottles and Jars Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Pharmaceutical Glass Bottles and Jars Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Pharmaceutical Glass Bottles and Jars Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Pharmaceutical Glass Bottles and Jars Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Pharmaceutical Glass Bottles and Jars Sales and Revenue by Type (2020-2031)
9.4 Central and South America Pharmaceutical Glass Bottles and Jars Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceutical Glass Bottles and Jars Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Pharmaceutical Glass Bottles and Jars Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Pharmaceutical Glass Bottles and Jars Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceutical Glass Bottles and Jars Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Gerresheimer
11.1.1 Gerresheimer Corporation Information
11.1.2 Gerresheimer Business Overview
11.1.3 Gerresheimer Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.1.4 Gerresheimer Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Gerresheimer Pharmaceutical Glass Bottles and Jars Sales by Product in 2024
11.1.6 Gerresheimer Pharmaceutical Glass Bottles and Jars Sales by Application in 2024
11.1.7 Gerresheimer Pharmaceutical Glass Bottles and Jars Sales by Geographic Area in 2024
11.1.8 Gerresheimer Pharmaceutical Glass Bottles and Jars SWOT Analysis
11.1.9 Gerresheimer Recent Developments
11.2 Schott
11.2.1 Schott Corporation Information
11.2.2 Schott Business Overview
11.2.3 Schott Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.2.4 Schott Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Schott Pharmaceutical Glass Bottles and Jars Sales by Product in 2024
11.2.6 Schott Pharmaceutical Glass Bottles and Jars Sales by Application in 2024
11.2.7 Schott Pharmaceutical Glass Bottles and Jars Sales by Geographic Area in 2024
11.2.8 Schott Pharmaceutical Glass Bottles and Jars SWOT Analysis
11.2.9 Schott Recent Developments
11.3 SGD
11.3.1 SGD Corporation Information
11.3.2 SGD Business Overview
11.3.3 SGD Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.3.4 SGD Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 SGD Pharmaceutical Glass Bottles and Jars Sales by Product in 2024
11.3.6 SGD Pharmaceutical Glass Bottles and Jars Sales by Application in 2024
11.3.7 SGD Pharmaceutical Glass Bottles and Jars Sales by Geographic Area in 2024
11.3.8 SGD Pharmaceutical Glass Bottles and Jars SWOT Analysis
11.3.9 SGD Recent Developments
11.4 Nipro
11.4.1 Nipro Corporation Information
11.4.2 Nipro Business Overview
11.4.3 Nipro Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.4.4 Nipro Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Nipro Pharmaceutical Glass Bottles and Jars Sales by Product in 2024
11.4.6 Nipro Pharmaceutical Glass Bottles and Jars Sales by Application in 2024
11.4.7 Nipro Pharmaceutical Glass Bottles and Jars Sales by Geographic Area in 2024
11.4.8 Nipro Pharmaceutical Glass Bottles and Jars SWOT Analysis
11.4.9 Nipro Recent Developments
11.5 Stevanato Group
11.5.1 Stevanato Group Corporation Information
11.5.2 Stevanato Group Business Overview
11.5.3 Stevanato Group Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.5.4 Stevanato Group Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Stevanato Group Pharmaceutical Glass Bottles and Jars Sales by Product in 2024
11.5.6 Stevanato Group Pharmaceutical Glass Bottles and Jars Sales by Application in 2024
11.5.7 Stevanato Group Pharmaceutical Glass Bottles and Jars Sales by Geographic Area in 2024
11.5.8 Stevanato Group Pharmaceutical Glass Bottles and Jars SWOT Analysis
11.5.9 Stevanato Group Recent Developments
11.6 Ardagh
11.6.1 Ardagh Corporation Information
11.6.2 Ardagh Business Overview
11.6.3 Ardagh Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.6.4 Ardagh Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Ardagh Recent Developments
11.7 Bormioli Pharma
11.7.1 Bormioli Pharma Corporation Information
11.7.2 Bormioli Pharma Business Overview
11.7.3 Bormioli Pharma Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.7.4 Bormioli Pharma Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Bormioli Pharma Recent Developments
11.8 West Pharmaceutical
11.8.1 West Pharmaceutical Corporation Information
11.8.2 West Pharmaceutical Business Overview
11.8.3 West Pharmaceutical Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.8.4 West Pharmaceutical Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 West Pharmaceutical Recent Developments
11.9 Sisecam Group
11.9.1 Sisecam Group Corporation Information
11.9.2 Sisecam Group Business Overview
11.9.3 Sisecam Group Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.9.4 Sisecam Group Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Sisecam Group Recent Developments
11.10 Corning Incorporated
11.10.1 Corning Incorporated Corporation Information
11.10.2 Corning Incorporated Business Overview
11.10.3 Corning Incorporated Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.10.4 Corning Incorporated Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Corning Incorporated Recent Developments
11.11 PGP Glass
11.11.1 PGP Glass Corporation Information
11.11.2 PGP Glass Business Overview
11.11.3 PGP Glass Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.11.4 PGP Glass Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 PGP Glass Recent Developments
11.12 Stoelzle Glass
11.12.1 Stoelzle Glass Corporation Information
11.12.2 Stoelzle Glass Business Overview
11.12.3 Stoelzle Glass Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.12.4 Stoelzle Glass Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Stoelzle Glass Recent Developments
11.13 Shandong Pharmaceutical Glass
11.13.1 Shandong Pharmaceutical Glass Corporation Information
11.13.2 Shandong Pharmaceutical Glass Business Overview
11.13.3 Shandong Pharmaceutical Glass Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.13.4 Shandong Pharmaceutical Glass Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Shandong Pharmaceutical Glass Recent Developments
11.14 Roetell
11.14.1 Roetell Corporation Information
11.14.2 Roetell Business Overview
11.14.3 Roetell Pharmaceutical Glass Bottles and Jars Product Models, Descriptions and Specifications
11.14.4 Roetell Pharmaceutical Glass Bottles and Jars Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Roetell Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Pharmaceutical Glass Bottles and Jars Industry Chain
12.2 Pharmaceutical Glass Bottles and Jars Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Pharmaceutical Glass Bottles and Jars Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Pharmaceutical Glass Bottles and Jars Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceutical Glass Bottles and Jars Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceutical Glass Bottles and Jars Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Pharmaceutical Glass Bottles and Jars Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Glass Bottles and Jars Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Glass Bottles and Jars Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Glass Bottles and Jars Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Glass Bottles and Jars Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Pharmaceutical Glass Bottles and Jars Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Pharmaceutical Glass Bottles and Jars Sales by Region (2020-2025) & (K Units)
Table 8. Global Pharmaceutical Glass Bottles and Jars Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Pharmaceutical Glass Bottles and Jars Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Pharmaceutical Glass Bottles and Jars Sales Share by Manufacturers (2020-2025)
Table 12. Global Pharmaceutical Glass Bottles and Jars Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Pharmaceutical Glass Bottles and Jars Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Pharmaceutical Glass Bottles and Jars by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Glass Bottles and Jars as of 2024)
Table 16. Global Pharmaceutical Glass Bottles and Jars Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Pharmaceutical Glass Bottles and Jars Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Pharmaceutical Glass Bottles and Jars Manufacturing Base and Headquarters
Table 19. Global Pharmaceutical Glass Bottles and Jars Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Pharmaceutical Glass Bottles and Jars Sales by Type (2020-2025) & (K Units)
Table 23. Global Pharmaceutical Glass Bottles and Jars Sales by Type (2026-2031) & (K Units)
Table 24. Global Pharmaceutical Glass Bottles and Jars Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Pharmaceutical Glass Bottles and Jars Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Pharmaceutical Glass Bottles and Jars ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Pharmaceutical Glass Bottles and Jars Sales by Application (2020-2025) & (K Units)
Table 29. Global Pharmaceutical Glass Bottles and Jars Sales by Application (2026-2031) & (K Units)
Table 30. Pharmaceutical Glass Bottles and Jars High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Pharmaceutical Glass Bottles and Jars Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Pharmaceutical Glass Bottles and Jars Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Pharmaceutical Glass Bottles and Jars ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Pharmaceutical Glass Bottles and Jars Growth Accelerators and Market Barriers
Table 37. North America Pharmaceutical Glass Bottles and Jars Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Pharmaceutical Glass Bottles and Jars Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Pharmaceutical Glass Bottles and Jars Growth Accelerators and Market Barriers
Table 40. Europe Pharmaceutical Glass Bottles and Jars Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Pharmaceutical Glass Bottles and Jars Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Pharmaceutical Glass Bottles and Jars Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Pharmaceutical Glass Bottles and Jars Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Pharmaceutical Glass Bottles and Jars Growth Accelerators and Market Barriers
Table 45. Southeast Asia Pharmaceutical Glass Bottles and Jars Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Pharmaceutical Glass Bottles and Jars Investment Opportunities and Key Challenges
Table 47. Central and South America Pharmaceutical Glass Bottles and Jars Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Pharmaceutical Glass Bottles and Jars Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Pharmaceutical Glass Bottles and Jars Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Gerresheimer Corporation Information
Table 51. Gerresheimer Description and Major Businesses
Table 52. Gerresheimer Product Models, Descriptions and Specifications
Table 53. Gerresheimer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Gerresheimer Sales Value Proportion by Product in 2024
Table 55. Gerresheimer Sales Value Proportion by Application in 2024
Table 56. Gerresheimer Sales Value Proportion by Geographic Area in 2024
Table 57. Gerresheimer Pharmaceutical Glass Bottles and Jars SWOT Analysis
Table 58. Gerresheimer Recent Developments
Table 59. Schott Corporation Information
Table 60. Schott Description and Major Businesses
Table 61. Schott Product Models, Descriptions and Specifications
Table 62. Schott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Schott Sales Value Proportion by Product in 2024
Table 64. Schott Sales Value Proportion by Application in 2024
Table 65. Schott Sales Value Proportion by Geographic Area in 2024
Table 66. Schott Pharmaceutical Glass Bottles and Jars SWOT Analysis
Table 67. Schott Recent Developments
Table 68. SGD Corporation Information
Table 69. SGD Description and Major Businesses
Table 70. SGD Product Models, Descriptions and Specifications
Table 71. SGD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. SGD Sales Value Proportion by Product in 2024
Table 73. SGD Sales Value Proportion by Application in 2024
Table 74. SGD Sales Value Proportion by Geographic Area in 2024
Table 75. SGD Pharmaceutical Glass Bottles and Jars SWOT Analysis
Table 76. SGD Recent Developments
Table 77. Nipro Corporation Information
Table 78. Nipro Description and Major Businesses
Table 79. Nipro Product Models, Descriptions and Specifications
Table 80. Nipro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Nipro Sales Value Proportion by Product in 2024
Table 82. Nipro Sales Value Proportion by Application in 2024
Table 83. Nipro Sales Value Proportion by Geographic Area in 2024
Table 84. Nipro Pharmaceutical Glass Bottles and Jars SWOT Analysis
Table 85. Nipro Recent Developments
Table 86. Stevanato Group Corporation Information
Table 87. Stevanato Group Description and Major Businesses
Table 88. Stevanato Group Product Models, Descriptions and Specifications
Table 89. Stevanato Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Stevanato Group Sales Value Proportion by Product in 2024
Table 91. Stevanato Group Sales Value Proportion by Application in 2024
Table 92. Stevanato Group Sales Value Proportion by Geographic Area in 2024
Table 93. Stevanato Group Pharmaceutical Glass Bottles and Jars SWOT Analysis
Table 94. Stevanato Group Recent Developments
Table 95. Ardagh Corporation Information
Table 96. Ardagh Description and Major Businesses
Table 97. Ardagh Product Models, Descriptions and Specifications
Table 98. Ardagh Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Ardagh Recent Developments
Table 100. Bormioli Pharma Corporation Information
Table 101. Bormioli Pharma Description and Major Businesses
Table 102. Bormioli Pharma Product Models, Descriptions and Specifications
Table 103. Bormioli Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Bormioli Pharma Recent Developments
Table 105. West Pharmaceutical Corporation Information
Table 106. West Pharmaceutical Description and Major Businesses
Table 107. West Pharmaceutical Product Models, Descriptions and Specifications
Table 108. West Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. West Pharmaceutical Recent Developments
Table 110. Sisecam Group Corporation Information
Table 111. Sisecam Group Description and Major Businesses
Table 112. Sisecam Group Product Models, Descriptions and Specifications
Table 113. Sisecam Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Sisecam Group Recent Developments
Table 115. Corning Incorporated Corporation Information
Table 116. Corning Incorporated Description and Major Businesses
Table 117. Corning Incorporated Product Models, Descriptions and Specifications
Table 118. Corning Incorporated Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Corning Incorporated Recent Developments
Table 120. PGP Glass Corporation Information
Table 121. PGP Glass Description and Major Businesses
Table 122. PGP Glass Product Models, Descriptions and Specifications
Table 123. PGP Glass Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. PGP Glass Recent Developments
Table 125. Stoelzle Glass Corporation Information
Table 126. Stoelzle Glass Description and Major Businesses
Table 127. Stoelzle Glass Product Models, Descriptions and Specifications
Table 128. Stoelzle Glass Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Stoelzle Glass Recent Developments
Table 130. Shandong Pharmaceutical Glass Corporation Information
Table 131. Shandong Pharmaceutical Glass Description and Major Businesses
Table 132. Shandong Pharmaceutical Glass Product Models, Descriptions and Specifications
Table 133. Shandong Pharmaceutical Glass Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Shandong Pharmaceutical Glass Recent Developments
Table 135. Roetell Corporation Information
Table 136. Roetell Description and Major Businesses
Table 137. Roetell Product Models, Descriptions and Specifications
Table 138. Roetell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Roetell Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Glass Bottles and Jars Product Picture
Figure 2. Global Pharmaceutical Glass Bottles and Jars Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Type I Glass Bottles Product Picture
Figure 4. Type II Glass Bottles Product Picture
Figure 5. Type III Glass Bottles Product Picture
Figure 6. Global Pharmaceutical Glass Bottles and Jars Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Injectable
Figure 8. Transfusion
Figure 9. Drug
Figure 10. Pharmaceutical Glass Bottles and Jars Report Years Considered
Figure 11. Global Pharmaceutical Glass Bottles and Jars Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 13. Global Pharmaceutical Glass Bottles and Jars Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Pharmaceutical Glass Bottles and Jars Revenue Market Share by Region (2020-2031)
Figure 15. Global Pharmaceutical Glass Bottles and Jars Sales (2020-2031) & (K Units)
Figure 16. Global Pharmaceutical Glass Bottles and Jars Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Pharmaceutical Glass Bottles and Jars Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Pharmaceutical Glass Bottles and Jars Sales Volume Market Share in 2024
Figure 19. Global Pharmaceutical Glass Bottles and Jars Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Type I Glass Bottles Revenue Market Share by Manufacturer in 2024
Figure 22. Type II Glass Bottles Revenue Market Share by Manufacturer in 2024
Figure 23. Type III Glass Bottles Revenue Market Share by Manufacturer in 2024
Figure 24. Global Pharmaceutical Glass Bottles and Jars Sales Market Share by Type (2020-2031)
Figure 25. Global Pharmaceutical Glass Bottles and Jars Revenue Market Share by Type (2020-2031)
Figure 26. Global Pharmaceutical Glass Bottles and Jars Sales Market Share by Application (2020-2031)
Figure 27. Global Pharmaceutical Glass Bottles and Jars Revenue Market Share by Application (2020-2031)
Figure 28. North America Pharmaceutical Glass Bottles and Jars Sales YoY (2020-2031) & (K Units)
Figure 29. North America Pharmaceutical Glass Bottles and Jars Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) in 2024
Figure 31. North America Pharmaceutical Glass Bottles and Jars Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Pharmaceutical Glass Bottles and Jars Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Pharmaceutical Glass Bottles and Jars Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Pharmaceutical Glass Bottles and Jars Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) in 2024
Figure 41. Europe Pharmaceutical Glass Bottles and Jars Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Pharmaceutical Glass Bottles and Jars Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 46. France Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Pharmaceutical Glass Bottles and Jars Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Pharmaceutical Glass Bottles and Jars Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Pharmaceutical Glass Bottles and Jars Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Pharmaceutical Glass Bottles and Jars Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 61. India Pharmaceutical Glass Bottles and Jars Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Pharmaceutical Glass Bottles and Jars Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Pharmaceutical Glass Bottles and Jars Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Pharmaceutical Glass Bottles and Jars Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Pharmaceutical Glass Bottles and Jars Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Pharmaceutical Glass Bottles and Jars Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Pharmaceutical Glass Bottles and Jars Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Pharmaceutical Glass Bottles and Jars Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Pharmaceutical Glass Bottles and Jars Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Pharmaceutical Glass Bottles and Jars Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Pharmaceutical Glass Bottles and Jars Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Pharmaceutical Glass Bottles and Jars Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Pharmaceutical Glass Bottles and Jars Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Pharmaceutical Glass Bottles and Jars Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Pharmaceutical Glass Bottles and Jars Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Pharmaceutical Glass Bottles and Jars Revenue (2020-2025) & (US$ Million)
Figure 82. Pharmaceutical Glass Bottles and Jars Industry Chain Mapping
Figure 83. Regional Pharmaceutical Glass Bottles and Jars Manufacturing Base Distribution (%)
Figure 84. Global Pharmaceutical Glass Bottles and Jars Production Market Share by Region (2020-2031)
Figure 85. Pharmaceutical Glass Bottles and Jars Production Process
Figure 86. Regional Pharmaceutical Glass Bottles and Jars Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
